Stock Screener App
Free
-
Play Store
App Store
Install
Install
Dark
EN
Sign in
Watchlist
Top Lists
Markets
New
Options
Cryptos
Industries
Elite
Market Simulator
KROS
$9.45
12.74%
-1.38
Keros Therapeutics Inc (KROS)
Indicator
5
EX
1min
5min
Hourly
Daily
Weekly
Monthly
Line
Candle
Overview
News
Price History
Option Chain
Financials
Discussions
Forecast
Similar to KROS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Keros Therapeutics Inc Stock (KROS) Financials Data
Income Statement
Quarterly
*All numbers in millions
Period End Date
2026-06-30
2026-03-31
2025-12-31
2025-09-30
2025-06-30
Period Length
3 Months
3 Months
3 Months
3 Months
3 Months
Revenues
100.00%
-
0.03
0.38
14.12
18.17
Operating Expenses
17.88%
30.94
26.24
29.66
29.65
57.99
Research and Development
38.73%
22.33
16.10
17.91
19.52
43.50
Operating Income/Loss
19.55%
-30.94
-25.88
-29.27
-15.38
-39.82
Nonoperating Income/Loss
2.67%
2.23
2.17
4.30
6.68
6.90
Income/Loss From Continuing Operations Before Tax
21.10%
-28.71
-23.71
-24.98
-8.70
-32.92
Income Tax Expense/Benefit
-
-
-1.51
-1.42
-2.22
Net Income/Loss
21.10%
-28.71
-23.71
-23.46
-7.28
-30.70
Attributable To Parent
21.10%
-28.71
-23.71
-23.46
-7.28
-30.70
Available To Common Stockholders, Basic
21.10%
-28.71
-23.71
-23.46
-7.28
-30.70
Basic Average Shares
0.87%
19.80
19.63
-3.38
40.62
40.61
Diluted Average Shares
0.87%
19.80
19.63
-3.34
40.62
40.61
Basic Earnings Per Share
19.83%
-1.45
-1.21
-0.38
-0.18
-0.76
Diluted Earnings Per Share
19.83%
-1.45
-1.21
-0.38
-0.18
-0.76
